We are proud to be one of the first certified SPRAVATO™ (esketamine) treatment centers in the country. SPRAVATO™ (esketamine) CIII Nasal Spray is indicated, in conjunction with an oral antidepressant (AD), for the treatment of treatment-resistant depression (TRD) in adults.
Semaglutide is a medication that serves a dual purpose: it is FDA-approved for both weight loss and the treatment of type 2 diabetes. Let’s delve into the details: